PUBLISHER: iGate Research | PRODUCT CODE: 1422638
PUBLISHER: iGate Research | PRODUCT CODE: 1422638
China in-vitro diagnostics market is predicted to reach US$ 28.13 Billion by 2030, from US$ 11.96 Billion in 2023. China is the largest in-vitro diagnostics market in the Asia-Pacific region, and only second to the United States in terms of value. In-vitro diagnostics refers to the diagnosis of disease or other condition of the human body through the collection, preparation, and testing of human samples with reagents, instruments, and systems. China is facing the challenges of fighting with infectious disease including HBV, TB, HCV and HIV, as well as various chronic diseases and cancer. In-vitro diagnostics plays an important role in the detection of infectious and chronic diseases.
Due to the upsurge of the geriatric population and the high burden of chronic and infectious diseases, like diabetes, cancer, and COVID-19, the China IVD market is slated to show significant growth, as these chronic disorders can be diagnosed and monitored using in-vitro diagnostics products. Moreover, Chinese government is taking number of initiatives to improve the healthcare sector in the country. For instance, The State Council issued a guideline to implement the country's Healthy China initiative to diminish the incidence of disability among elderly people aged between 65 and 74 years by offering medical and health services. Such initiatives by the government are expected to boost market growth over the forecast period. However, a lack of proper reimbursement and stringent regulatory framework restricts the market's growth.
China In-Vitro Diagnostics Market - Recent Developments
By Segment: China In-Vitro Diagnostics Market and Forecast - Key Takeaways
China In-Vitro Diagnostics Market - Company Analysis
iGATE RESEARCH report titled "China In-Vitro Diagnostics Market (By Segment, Company), Size, Share, Regulations, Reimbursement, Major Deals, Trends, Key Company Profiles, Sales Analysis, and Recent Developments - Forecast to 2030" provides a comprehensive analysis of the China In-Vitro Diagnostics (IVD) Market.
This 282 Page report with 43 Figures and 5 Tables has been analyzed from 12 View Points:
1) China IVD Market and Forecast (2014 - 2030)
2) China IVD Market Share and Forecast (2014 - 2030)
3) By Segment - China IVD Market & Forecast (2014 - 2030)
4) Development Environment and Regulatory Status in China IVD market
5) China IVD Market - Key Players Sales Analysis (2015 - 2030)
6) Registration for In-Vitro Diagnostic Reagents in China
7) Regulatory History/Status/Trends in China IVD Market
8) Reimbursement of IVD Products in China
9) Profiles of Select Private Clinical Labs and Diagnostic Services Companies
10) IVD Market - Major Deals
11) IVD Market - Recent Developments
12) China IVD Industry - Market Dynamics
China IVD Market - By Application Segment
China IVD Market - Key Company Profiles
Profiles of Private Clinical Labs and Diagnostic Services Companies in China
Data Source
iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.
Research Methodologies
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.